MMM
52
2
TXT
58
-2
VMC
57
-3
FE
55
5
PPL
65
6
ETR
68
2
HON
47
-12
BAX
30
-3
AIV
71
9
INTU
63
-2
EFX
63
-6
MSI
72
2
CNX
80
4
DIS
60
2
D
60
5
XRX
52
-3
IVZ
50
-3
R
66
-4
FRT
36
-2
L
55
-4
MMM
52
2
TXT
58
-2
VMC
57
-3
FE
55
5
PPL
65
6
ETR
68
2
HON
47
-12
BAX
30
-3
AIV
71
9
INTU
63
-2
EFX
63
-6
MSI
72
2
CNX
80
4
DIS
60
2
D
60
5
XRX
52
-3
IVZ
50
-3
R
66
-4
FRT
36
-2
L
55
-4
Financhill
Back

Direxion Daily S&P Biotech Bull 3X ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
39

LABU
Direxion Daily S&P Biotech Bull 3X ETF

Last Price:
140.31
Seasonality Move:
-4.28%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
39
Direxion Daily S&P Biotech Bull 3X ETF (LABU) is a Sell

Is Direxion Daily S&P Biotech Bull 3X ETF a Buy, Sell or Hold?

  • The current Direxion Daily S&P Biotech Bull 3X ETF [LABU] share price is $140.24. The Score for LABU is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • LABU is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

LABU Stock Price Chart

What is Direxion Daily S&P Biotech Bull 3X ETF's stock price today?

  • The Direxion Daily S&P Biotech Bull 3X ETF share price today is $140.24
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LABU is experiencing slight selling pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

LABU Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.35 Buy
Relative Strength Index (14 RSI): 56.78 Buy
Chaikin Money Flow: -12344 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (129.27 - 142.03) Buy
Bollinger Bands (100): (107.98 - 135.76) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

LABU Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 137.34 Buy
20-day SMA: 135.17 Buy
50-day SMA: 133.1 Buy
200-day SMA: 120.97 Buy
8-day EMA: 137.76 Buy
20-day EMA: 134.95 Buy
50-day EMA: 130.8 Buy
200-day EMA: 121.55 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Direxion Daily S&P Biotech Bull 3X ETF Earnings Growth & LABU Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Direxion Daily S&P Biotech Bull 3X ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):